| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.049 | 0.9 |